Search research articles
Contact Us
Filters
Showing results (31-40 of 37) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 37 results.
Neurobiology of Disease
|
March 5, 2018
Neuronal pentraxin 1: A synaptic-derived plasma biomarker in Alzheimer's disease
Qiu-Lan Ma, Edmond Teng, Xiaohong Zuo, et al.
Neurobiology of Disease
|
May 25, 2011
[F-18]FDDNP microPET imaging correlates with brain Aβ burden in a transgenic rat model of Alzheimer disease: effects of aging, in vivo blockade, and anti-Aβ antibody treatment
Edmond Teng, Vladimir Kepe, Sally A Frautschy, et al.
Biorxiv : the Preprint Server for Biology
|
July 14, 2025
13C tracing in synaptosomes reveals that SGLT2 inhibition with dapagliflozin prevents metabolic deficits in the 5X-FAD model of Alzheimer's Disease
Marisa Mekkittikul, Cansheng Zhu, Bezawit T Danna, et al.
JCI Insight
|
August 18, 2017
Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease
Yosef Koronyo, David Biggs, Ernesto Barron, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
April 13, 2022
A novel process driving Alzheimer's disease validated in a mouse model: Therapeutic potential
Susan A Greenfield, Gregory M Cole, Clive W Coen, et al.
ACS Chemical Neuroscience
|
January 5, 2026
In Vitro and In Vivo Evaluation of Small-Molecule Disassemblers of Pathological Tau Fibrils
Hope Pan, Xinyi Cheng, Jeffrey Zhang, et al.
NPJ Parkinson'S Disease
|
April 23, 2025
Liganded magnetic nanoparticles for magnetic resonance imaging of α-synuclein
Hope Pan, Melinda Balbirnie, Ke Hou, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 37) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 37 results.
Neurobiology of Disease
|
March 5, 2018
Neuronal pentraxin 1: A synaptic-derived plasma biomarker in Alzheimer's disease
Qiu-Lan Ma, Edmond Teng, Xiaohong Zuo, et al.
Neurobiology of Disease
|
May 25, 2011
[F-18]FDDNP microPET imaging correlates with brain Aβ burden in a transgenic rat model of Alzheimer disease: effects of aging, in vivo blockade, and anti-Aβ antibody treatment
Edmond Teng, Vladimir Kepe, Sally A Frautschy, et al.
Biorxiv : the Preprint Server for Biology
|
July 14, 2025
13C tracing in synaptosomes reveals that SGLT2 inhibition with dapagliflozin prevents metabolic deficits in the 5X-FAD model of Alzheimer's Disease
Marisa Mekkittikul, Cansheng Zhu, Bezawit T Danna, et al.
JCI Insight
|
August 18, 2017
Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease
Yosef Koronyo, David Biggs, Ernesto Barron, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
April 13, 2022
A novel process driving Alzheimer's disease validated in a mouse model: Therapeutic potential
Susan A Greenfield, Gregory M Cole, Clive W Coen, et al.
ACS Chemical Neuroscience
|
January 5, 2026
In Vitro and In Vivo Evaluation of Small-Molecule Disassemblers of Pathological Tau Fibrils
Hope Pan, Xinyi Cheng, Jeffrey Zhang, et al.
NPJ Parkinson'S Disease
|
April 23, 2025
Liganded magnetic nanoparticles for magnetic resonance imaging of α-synuclein
Hope Pan, Melinda Balbirnie, Ke Hou, et al.
Page
of 4